COGT Stock Analysis: Buy, Sell, or Hold?
COGT - Cogent Biosciences, Inc. Common Stock
$36.31
0.47 (1.31%)
▲
5d:
+9.47%
30d:
+11.45%
90d:
+2.54%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When COGT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: COGT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: COGT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: COGT is currently trading at $36.31, which is considered extended relative to its 30-day fair value range of $31.73 to $34.63.
Technical Outlook: Technically, COGT is in a downtrend. The price is approaching resistance at $36.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: COGT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $54.25 (+49.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, COGT is in a downtrend. The price is approaching resistance at $36.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: COGT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $54.25 (+49.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$31.73 -
$34.63
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 49.4% below Wall St target ($54.25)
Trading Range Analysis
30-Day Trading Range
$31.73 -
$34.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$30.93
Resistance Level
$36.90
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-37.99
Wall Street Target
$54.25
(+49.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 23, 2026 7:22 PM ET
Data refreshes hourly during market hours. Next update: 8:22 PM
Data refreshes hourly during market hours. Next update: 8:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COGT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Fairmount Funds Manageme…
SELL
3500000 shares
2026-01-22
Evan Kearns
SELL
65000 shares
2025-12-26
Jessica Sachs
SELL
82642 shares
2025-12-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$8 | 60 HOLD |
Advanced COGT Option Strategies
Professional options setups generated by AI based on today's COGT price and gamma walls.
